Statin-associated QTc interval shortening as prognostic indicator in heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 25, Issue 2, 2006, Pages 234-236

  Vrtovec, Bojan ^a,b   Stojanovic, Ivan ^a,c   Radovancevic, Rajko ^a,b   Yazdanbakhsh, Aria P ^a,d   Thomas, Cynthia D ^a,b   Radovancevic, Branislav ^a,e  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

^c Dedinje Cardiovascular Institute   (Serbia)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; AZATHIOPRINE DERIVATIVE; CYCLOSPORIN A; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PRAVASTATIN; PREDNISONE; SIMVASTATIN;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFECT; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; SURVIVAL;

EID: 31544432822     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.09.004     Document Type: Article

References (13)

1. J.A. Kobashigawa, S. Katznelson, H. Laks Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621 627
2. K. Wenke, B. Meiser, J. Thiery Simvastatin reduces graft vessel disease and mortality after heart transplantation a four-year randomized trial Circulation 96 1997 1398 1402
3. M. Weis, S. Pehlivanli, B.M. Meiser, W. von Scheidt Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation J Am Coll Cardiol 38 2001 814 818
4. T. Holm, A.K. Andreassen, T. Ueland Effect of pravastatin on plasma markers of inflammation and peripheral endothelial function in male heart transplant recipients Am J Cardiol 87 2001 815 818 A9
5. F. Mach Immunosuppressive effects of statins Atheroscler Suppl 3 2002 17 20
6. H. Elming, B. Brendorp, L. Kober, N. Sahebzadah, C. Torp-Petersen QTc interval in the assessment of cardiac risk Card Electrophysiol Rev 6 2002 289 294
7. B.M. Richartz, B. Radovancevic, M.T. Bologna, O.H. Frazier Usefulness of the QTc interval in predicting acute allograft rejection Thorac Cardiovasc Surg 46 1998 217 221
8. R.E. Eckart, M.W. Kolasa, N.A. Khan, M.D. Kwan, M.E. Peele Surface electrocardiography and histologic rejection following orthotopic heart transplantation Ann Noninvasive Electrocardiol 10 2005 60 64
9. K. Yokoyama, T. Ishibashi, H. Ohkawara HMG-CoA reductase inhibitors suppress intracellular calcium mobilization and membrane current induced by lysophosphatidylcholine in endothelial cells Circulation 105 2002 962 967
10. A. Ali, M.R. Mehra, F.S. Malik, P.A. Uber, H.O. Ventura Insights into ventricular repolarization abnormalities in cardiac allograft vasculopathy Am J Cardiol 87 2001 367 368 A10
11. B. Vrtovec, B. Radovancevic, G. Torre-Amione Immune modulation therapy decreases QTc interval duration in patients with severe chronic heart failure Circulation 107 2003 1764 1769
12. A.R. Magnano, S. Holleran, R. Ramakrishnan Autonomic nervous system influences on QT interval in normal subjects J Am Coll Cardiol 39 2002 1820 1826
13. F.M. Bengel, P. Ueberfuhr, S.I. Ziegler, S. Nekolla, B. Reichart, M. Schwaiger Serial assessment of sympathetic reinnervation after orthotopic heart transplantation a longitudinal study using PET and C-11 hydroxyephedrine Circulation 99 1999 1866 1871